Dr. Faisal Yasir Ridha Al-Timimi, MD

Dr. Ridha Al-Timimi practices at New Millennium Surgery Center in Southfield, Michigan.

Dr. Ridha Al-Timimi's NPI, 1316358773, was assigned on May 19, 2014. Dr. Ridha Al-Timimi holds Michigan license 4301114254.

Dr. Ridha Al-Timimi's primary practice is New Millennium Surgery Center, at 29201 Telegraph Road, Suite 315, Southfield, MI 48034. The practice phone is (248) 281-0028.

Dr. Ridha Al-Timimi's primary practice is New Millennium Surgery Center in Southfield, Michigan. Dr. Ridha Al-Timimi is also affiliated with Straith Hospital for Special Surgery. The medical group on file is Beaumont Medical Group - Specialty Services. Dmand AI also links Dr. Ridha Al-Timimi to 1 more hospital, 4 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ridha Al-Timimi practices, 7 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Ridha Al-Timimi's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dmand AI has Dr. Ridha Al-Timimi's licenses on file in 3 states: Michigan, District of Columbia and Ohio.

CMS data shows 2,017 Medicare services from Dr. Ridha Al-Timimi across 17 procedure codes in 2024, for 352 Medicare patients. Medicare paid $97,482 for them.

CMS counts 352 Medicare patients who saw Dr. Ridha Al-Timimi in 2024. The largest group is 65 to 74, with 153 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 23% are also on Medicaid. Their average risk score is 1.39, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ridha Al-Timimi's median patient age at 72, with 52% women.

In 2024, Dr. Ridha Al-Timimi wrote 3,457 Medicare Part D claims for 779 patients. 71% of them were for generic drugs. CMS names the drug for 3,367 of them, across 27 drugs with 11 or more claims each, at $201,920 in total drug cost. In 2023, CMS named 5,607 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Ridha Al-Timimi for performance year 2024, reported as part of a group. Dr. Ridha Al-Timimi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 64 procedures of cataract surgery by Dr. Ridha Al-Timimi, more than 67% of the clinicians it reports for that procedure.

CMS Open Payments shows 71 general payments to Dr. Ridha Al-Timimi from 14 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Sight Sciences, Inc. paid the most, $904.